6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Hyperglycemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davargaon, RS; Muthangi V V, S; Sambe, AD | 1 |
Ansari, NH; Bhatnagar, A; Fulep, E; Khanna, P; Srivastava, SK | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Hyperglycemia
Article | Year |
---|---|
Trolox prevents high glucose-induced apoptosis in rat myocardial H9c2 cells by regulating GLUT-4 and antioxidant defense mechanism.
Topics: Animals; Antioxidants; Apoptosis; Chromans; Cytochromes c; Enzymes; Glucose; Glucose Transporter Type 4; Glutathione; Hyperglycemia; Myocytes, Cardiac; Oxidative Stress; Rats | 2019 |
Trolox protects hyperglycemia-induced cataractogenesis in cultured rat lens.
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Cataract; Cells, Cultured; Chromans; Drug Interactions; Hyperglycemia; Male; Rats; Rats, Sprague-Dawley; Sorbitol | 1994 |